Rare pediatric tumors benefit from large clinical trials: The story of undifferentiated embryonal sarcoma of the liver
Cancer · 2024
DOI: 10.1002/cncr.35327 ↗Kurz gefasst
Editorial in der Zeitschrift Cancer, 2024. Verfasst von Max M van Noesel. Beteiligte Einrichtung: Department of Solid Tumors, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Liver Neoplasms, Neoplasms, Germ Cell and Embryonal, Sarcoma. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This editorial provides a comprehensive summary of two clinical trials on undifferentiated embryonal sarcoma of the liver from the major sarcoma groups in the American Children’s Oncology Group and the European Paediatric Soft Tissue Sarcoma Study Group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Solid Tumors, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
ORCID-Profile: Max M van Noesel
Zitieren
APA
van Noesel, M. M. (2024). Rare pediatric tumors benefit from large clinical trials: The story of undifferentiated embryonal sarcoma of the liver. Cancer. https://doi.org/10.1002/cncr.35327
Vancouver
van Noesel MM. Rare pediatric tumors benefit from large clinical trials: The story of undifferentiated embryonal sarcoma of the liver. Cancer. 2024. doi:10.1002/cncr.35327
BibTeX
@article{vanNoesel2024,
author = {van Noesel, Max M},
title = {Rare pediatric tumors benefit from large clinical trials: The story of undifferentiated embryonal sarcoma of the liver},
journal = {Cancer},
year = {2024},
doi = {10.1002/cncr.35327}
}
EUVIMED